跳至主要内容
临床试验/NCT07061496
NCT07061496已完成不适用

Comparative Effects of Exercise and Metformin on Glycemic Control in Prediabetic Adults: A Community-Based, Open-Label, Randomized Trial in a Low-Resource Setting

Asad Ullah Jan2 个研究点 分布在 1 个国家目标入组 226 人开始时间: 2025年8月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
226
试验地点
2
主要终点
Change in Glycated Hemoglobin (HbA1c) from Baseline to 12 Weeks

研究概览

简要总结

This study is being done to compare the effect of regular exercise and metformin in people who have prediabetes. It is a community-based, open-label, randomized trial in which eligible participants will be divided into two groups. One group will do moderate physical exercise, and the other group will take metformin for 12 weeks. We will check their fasting blood sugar and HbA1c before and after the treatment to see which method works better for controlling sugar levels. The study is being done in a low-resource community setup to see which option is more practical and effective in real-life Pakistani settings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18 to 59 years
  • Diagnosed with prediabetes based on ADA criteria (FPG: 100-125 mg/dL or HbA1c: 5.7-6.4%)
  • Stable HbA1c levels (no significant fluctuation in the last 3 months)
  • Body Mass Index (BMI) less than 30 kg/m²
  • Willing and able to provide written informed consent
  • Willing to participate in the assigned intervention (exercise or metformin) for 12 weeks
  • Residing within the community and able to attend scheduled follow-ups

排除标准

  • Age 60 years or older
  • Diagnosis of Type 2 Diabetes Mellitus (T2DM) or use of anti-diabetic medications
  • Family history of diabetes in first-degree relatives (parent or sibling)
  • Known cardiovascular, renal, or hepatic disease
  • Pregnancy or lactation
  • Physical disability or limitation that would interfere with performing moderate-intensity exercise
  • Uncontrolled hypertension (SBP ≥ 160 mmHg or DBP ≥ 100 mmHg)
  • Known allergy or contraindication to metformin
  • Alcohol or substance abuse

研究组 & 干预措施

Exercise Group

Experimental

Moderate aerobic activity (e.g., brisk walking) for 30-45 minutes/day, 5 days/week, for 12 weeks.

干预措施: Moderately intense exercise (Behavioral)

Metformin Group

Active Comparator

Participants will receive oral metformin 500 mg twice daily for 12 weeks.

干预措施: MetFORMIN 500 Mg Oral Tablet (Drug)

结局指标

主要结局

Change in Glycated Hemoglobin (HbA1c) from Baseline to 12 Weeks

时间窗: Baseline and 12 week

HbA1c (%) will be measured to assess glycemic improvement following 12 weeks of intervention.

次要结局

  • Weight change(Baseline to 12 weeks)

研究者

发起方
Asad Ullah Jan
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

Asad Ullah Jan

Consultant Psychiatrist

Combined Military Hospital Nowshera

研究点 (2)

Loading locations...

相似试验